Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Imperva Company Profile (NASDAQ:IMPV)

Consensus Ratings for Imperva (NASDAQ:IMPV) (?)
Ratings Breakdown: 3 Hold Rating(s), 10 Buy Rating(s)
Consensus Rating:Buy (Score: 2.77)
Consensus Price Target: $57.50 (5.44% downside)

Current Analysts' Coverage Summary for Imperva (NASDAQ:IMPV)
Show:
DateFirmActionRatingPrice TargetActions
5/18/2015RBC CapitalReiterated RatingOutperform$58.00 -> $61.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/14/2015Imperial CapitalBoost Price TargetOutperform$48.00 -> $63.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/14/2015Piper JaffrayBoost Price TargetOverweight$57.00 -> $66.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2015Citigroup Inc.Boost Price Target$58.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2015Pacific CrestBoost Price TargetOverweight$52.00 -> $56.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2015JPMorgan Chase & Co.Boost Price TargetNeutral$45.00 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2015Deutsche BankBoost Price TargetBuy$48.00 -> $58.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2015Topeka Capital MarketsBoost Price TargetHold$45.00 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2015Needham & Company LLCBoost Price TargetBuy$48.00 -> $67.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2015OppenheimerBoost Price TargetOutperform$55.00 -> $58.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/6/2015BMO Capital MarketsLower Price TargetOutperform$56.00 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/16/2015Buckingham ResearchInitiated CoverageNeutral$53.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2014NomuraInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/11/2014MacquarieInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/2/2014BarclaysLower Price TargetOverweight$60.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/16/2014WedbushInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/11/2014Sterne Agee CRTUpgradeNeutral -> Buy$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/11/2013Lazard Capital MarketsBoost Price TargetBuy$44.00 -> $52.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/29/2013 forward)